April 1, 2024 C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
June 16, 2024-June 20, 2024 Join C-Path at DIA Global 2024 C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming...
June 3, 2024-June 6, 2024 Connect with C-Path at BIO 2024: Join us on the path forward in drug development C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming BIO 2024 Conference. In two featured sessions...
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...
March 25, 2024 C-Path to Spearhead New Task Force Dedicated to Accelerating Drug Development for Progressive Supranuclear Palsy Critical Path Institute (C-Path) today announced the formation of a new task force...
March 8, 2024 Rare Neurodegenerative Disease Efforts Under the ACT for ALS In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss...
March 15, 2024 C-Path’s CURE Drug Repurposing Collaboratory Aims to Document 1,000 Cases on the CURE ID App for Long COVID Awareness Day TUCSON, Ariz., March 15, 2024 — Critical Path Institute’s (C-Path) CURE Drug Repurposing Collaboratory (CDRC), a leading advoc
March 14, 2024 Improving Data Collection for Rare Epilepsies: Case example from the TSC Natural History Presented by Elizabeth Cassidy, MPH from TSC Alliance...